Iron-deficiency anemia
Drug research and approvals for iron-deficiency anemia: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 85 studies of iron-deficiency anemia are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 85
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- A Phase 3 Evaluation of Sutacimig in Glanzmann ThrombastheniaNCT07935356 · Phase 3 · Hemab ApS · starts Oct 27, 2026
- Iron Treatment for Iron Deficiency Anemia in Children and Young Adults With Crohn's DiseaseNCT07925450 · Phase 4 · Weill Medical College of Cornell University · starts Sep 13, 2023
- Safety and Efficacy of Iron Prophylaxis With on Iron Homeostasis in Healthy Pregnant WomenNCT07884617 · Not applicable · IBSA Farmaceutici Italia Srl · starts May 18, 2026
- Donor Breast Milk 2NCT07816601 · Not applicable · AdventHealth · starts May 6, 2026
- Preconception vs First-Trimester Screening and Treatment for Iron Deficiency AnemiaNCT07811765 · Not applicable · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · starts Jul 10, 2026
- Iron Deficiency at ICU DischargeNCT07781540 · Not reported · Università degli Studi di Ferrara · starts Jul 29, 2026
- Iron Status Assessment in Geriatric ElderlyNCT07739524 · Not reported · Centre Hospitalier Régional d'Orléans · starts Aug 4, 2026
- A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron…NCT07687784 · Phase 3 · AFT Pharmaceuticals, Ltd. · starts Nov 1, 2026
- FACE-APPS-Based Approach for Improving Iron Deficiency Anaemia Indicators Among Female Adolescents at Marginalized…NCT07633262 · Not applicable · Cairo University · starts May 24, 2026
Approved 22
- Ferric carboxymaltoseSupplement
- Iron sucroseSupplement
- Ferric derisomaltoseSupplement
- Iron dextranSupplement
- Ascorbic acidSupplement
- Folic acid
- Zinc oxideSunscreen/skin protectant
- CholecalciferolVitamin D receptor agonist
- Cupric sulfate
- Levomefolic acid
- Ferric maltolSupplement
- DocusateSurfactant laxative
- Thiamine ionSupplement
- PyridoxineSupplement
- CyanocobalaminSupplement
- Biotin
- Niacin
- Niacinamide
- Riboflavin
- Zinc sulfate
- Sodium ascorbate
- Magnesium oxide
Phase 3 3
Phase 2 2
- Sodium ferric gluconate complexSupplement
- KER-047
Phase 1 or earlier 1
How its trials ended
602 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 140 whose ending is known, 55% met their primary endpoint, 8% missed it and 37% stopped early.
- Completed, result not reported27846%
- Ongoing9916%
- Status unknown8514%
- Met its primary endpoint7713%
- Stopped: other or unclear325%
- Stopped: enrollment or feasibility142%
- Missed its primary endpoint112%
- Stopped: sponsor or business decision41%
- Stopped: lack of efficacy1<1%
- Stopped: funding1<1%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA